Interiglin 20mg Injection

Aperçu du produit

About Interiglin

Interiglin is a medication containing the active ingredient Eptifibatide, classified as Platelet Aggregation Inhibitor. Eptifibatide, is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class. Eptifibatide is a cyclic heptapeptide derived from a disintegrin protein found in the venom of the southeastern pygmy rattlesnake. It belongs to the class of the arginine-glycine-aspartate-mimetics and reversibly binds to platelets.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Eptifibatide injection is a platelet aggregation inhibitor indicated for: Treatment of acute coronary syndrome (ACS) managed.
• Used for: 1) Treatment of patients undergoing PCI (including intracoronary stenting) (1
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Eptifibatide, the active ingredient in Interiglin, belongs to the Platelet Aggregation Inhibitor class. 1 INDICATIONS AND USAGE Eptifibatide injection is a platelet aggregation inhibitor indicated for: Treatment of acute coronary syndrome (ACS) managed medically or with percutaneous coronary intervention (PCI) (1. 1) Treatment of patients undergoing PCI (including intracoronary stenting) (1. 2) 1. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Interiglin. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Interiglin for extended periods without medical advice.